Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Teledermatology could improve skin care access, but its success depends on technology, quality strategies, and payment policies; also, vitamin B12 might help treat a specific hair loss condition.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Thyroid ultrasounds are essential but need skill and experience for accurate results.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Revertant cell therapy could be a future treatment for Ichthyosis with confetti.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Red light therapy can boost athletic performance and aid healing.

Too much thymosin beta4 causes weird teeth and more hair growth in mice.

Low-level laser therapy is a safe, painless method that effectively treats acne and improves skin without post-treatment care.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Tralokinumab may help improve symptoms of atopic dermatitis and alopecia areata.

The FDA did not approve a testosterone drug because of safety concerns.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Light-based bioelectronic devices improve health monitoring and disease treatment.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Technology, like stem cell therapy and teledermatology, is improving dermatology care.

Activating PKM2 and Wnt/β-catenin signaling speeds up wound healing.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A child's scalp infection was caused by a fungus not previously known to do so, but it was successfully treated.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.